Rigel Pharmaceuticals Q3 2025 Earnings Preview
2025-11-03 17:35:55 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion
- Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout
- Rigel targets up to $280M 2025 revenue as IRA boosts sales and pipeline advances
- Seeking Alpha’s Quant Rating on Rigel Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals Q3 2025 Earnings PreviewNASDAQ: RIGL
RIGL Trading
-4.89% G/L:
$28.02 Last:
129,381 Volume:
$28.28 Open:



